MONTREAL, May 28, 2019
I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the signing of a partnership agreement with prolens AG for exclusive distribution rights of I-LID ’N LASH®, I-LID ’N LASH® PLUS and the I-PEN® Tear Osmolarity System in Switzerland.
Philipp Binder, Vice-President of I-MED Pharma stated, “We are delighted to be partnering with the largest Swiss supplier of dry eye products that service opticians, optometrists and ophthalmologists. With the signing of this agreement, I-MED Pharma continues to expand its reach into the international marketplace to bring the most innovative dry eye products and diagnostic tools to the Swiss eye care professional community.”
I-MED Pharma is a privately held Canadian company, headquartered in Montreal, Quebec, servicing Canadian ophthalmologists, optometrists and the global eye care community. Established thirty years ago, I-MED Pharma Inc. creates and distributes innovative medical, surgical and veterinary eye care products. It continually researches, develops and sources the most effective and advanced solutions to eye disorders like cataracts, corneal degenerations, glaucoma, dry eye and meibomian gland disease.
I-MED Pharma is proud to have been at the forefront of managing Dry Eye Syndrome as a serious disease and invests heavily in researching and developing effective dry eye products. I-MED Pharma’s ocular surface disease product range includes dry eye drops, ocular hygiene, nutrition, therapeutic accessories and ocular occlusion devices.
Prolens is a Swiss supplier of contact lenses, eye care products, accessories and everything you need for dry eye, servicing opticians, optometrists and ophthalmologists. In business since 1959, prolens is all about eyes, and its product offering is complemented by concepts and tools.